We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+4.93%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.8B
AUM Growth
+$1.89B
(+9%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
15.02%
Holding
3,143
New
326
Increased
869
Reduced
968
Closed
274
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$125M |
| 2 |
Southwest Airlines
LUV
|
+$121M |
| 3 |
Lam Research
LRCX
|
+$101M |
| 4 |
DuPont de Nemours
DD
|
+$92.3M |
| 5 |
NetApp
NTAP
|
+$74.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$91.2M |
| 2 |
Tyson Foods
TSN
|
+$72.4M |
| 3 |
Merck
MRK
|
+$67.7M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$67.1M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$65.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.59% |
| 2 | Technology | 15.59% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 10.36% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
AstraZeneca
AZN
$263B
| $11.5M | 0.05% |
169,710
+20,638
| +14% | +$1.3M |
|
327
Invesco FTSE RAFI US 1000 ETF
PRF
$9.73B
| $11.3M | 0.05% |
525,405
-33,635
| -6% | -$704K |
|
328
RenaissanceRe
RNR
$13.7B
| $11.1M | 0.05% |
82,109
-1,609
| -2% | -$226K |
|
329
Lamar Advertising Co
LAMR
$16.2B
| $11M | 0.05% |
160,371
+3,984
| +3% | +$270K |
|
330
Eastman Chemical
EMN
$7.8B
| $10.7M | 0.05% |
118,184
+88,122
| +293% | +$7.5M |
|
331
American Electric Power
AEP
$73.7B
| $10.6M | 0.05% |
150,516
-2,328
| -2% | -$166K |
|
|
ATVI
332
DELISTED
Activision Blizzard
ATVI
| $10.4M | 0.05% |
160,935
-55,467
| -26% | -$3.46M |
|
333
DTE Energy
DTE
$31.1B
| $10.3M | 0.05% |
112,746
+17,347
| +18% | +$1.61M |
|
|
PDCE
334
DELISTED
PDC Energy, Inc.
PDCE
| $10.3M | 0.05% |
209,876
-212,221
| -50% | -$9.13M |
|
335
General Dynamics
GD
$105B
| $10.2M | 0.04% |
49,716
+784
| +2% | +$157K |
|
336
Adobe
ADBE
$89.5B
| $10.1M | 0.04% |
67,625
-5,672
| -8% | -$846K |
|
|
STI
337
DELISTED
SunTrust Banks, Inc.
STI
| $10.1M | 0.04% |
168,315
-1,712
| -1% | -$96.8K |
|
338
Kinder Morgan
KMI
$73.1B
| $9.92M | 0.04% |
517,310
-732,846
| -59% | -$14.3M |
|
|
SCHW
339
Charles Schwab
SCHW
$177B
| $9.8M | 0.04% |
224,071
-23,127
| -9% | -$960K |
|
340
CSX Corp
CSX
$98.6B
| $9.68M | 0.04% |
535,050
-103,053
| -16% | -$1.77M |
|
|
WCG
341
DELISTED
Wellcare Health Plans, Inc.
WCG
| $9.63M | 0.04% |
56,058
+9,611
| +21% | +$1.68M |
|
342
Duke Energy
DUK
$102B
| $9.53M | 0.04% |
113,517
+16,467
| +17% | +$1.41M |
|
343
Norfolk Southern
NSC
$78.8B
| $9.5M | 0.04% |
71,848
-64
| -0.1% | -$7.78K |
|
344
CME Group
CME
$92.2B
| $9.41M | 0.04% |
69,377
+4,917
| +8% | +$621K |
|
345
SPDR Gold Trust
GLD
$131B
| $9.37M | 0.04% |
77,048
+23
| +0% | +$2.8K |
|
|
TWX
346
DELISTED
Time Warner Inc
TWX
| $9.21M | 0.04% |
89,868
-284,467
| -76% | -$28.9M |
|
347
Sony
SONY
$123B
| $9.11M | 0.04% |
1,219,870
+913,500
| +298% | +$7.15M |
|
348
United Therapeutics
UTHR
$26.3B
| $9.09M | 0.04% |
77,563
-156,072
| -67% | -$19.9M |
|
349
Xcel Energy
XEL
$51B
| $8.91M | 0.04% |
188,288
+31,200
| +20% | +$1.5M |
|
350
Equifax
EFX
$20.3B
| $8.83M | 0.04% |
83,283
-171,813
| -67% | -$22.7M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2017 Portfolio in Review
As of Q3 2017, Glenmede Trust held 3,143 positions worth $22.8B, up 9% from $20.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust's Q3 2017 filing shows 326 new, 869 increased, 968 reduced and 274 closed positions. Its largest new stake was Five Below: 1,137,870 shares worth $62.4M. The largest sale was Du Pont De Nemours E I, an estimated $91.2M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
- Glenmede Trust's largest Q3 2017 buy was Five Below: 1,137,870 shares worth $62.4M.
- Glenmede Trust added most to Constellation Brands in Q3 2017, an estimated $125M increase.
- Glenmede Trust's biggest Q3 2017 reduction was Tyson Foods, cutting an estimated $72.4M.
- Glenmede Trust fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $91.2M.
- Glenmede Trust's ten largest holdings make up 15% of its $22.8B portfolio in Q3 2017.
- Glenmede Trust opened 326 new positions and closed 274 in Q3 2017.
- Glenmede Trust's portfolio value rose 9% quarter-over-quarter to $22.8B.
Based on Glenmede Trust's 13F filing for Q3 2017, filed 14 Nov 2017.